PT0511

· PAQ Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PT0511, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors [Phase 1]